Use of amniotic fluid for determining pregnancies at risk of preterm birth and for studying diseases of potential environmental etiology

Environmental Research

Volumn 136, Issue , 2015, Pages 470-481

  Geer, Laura A ^a   Pycke, Benny F G ^b   Sherer, David M ^c   Abulafia, Ovadia ^c   Halden, Rolf U ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c Downstate Health Sciences University   (United States)

Author keywords

Amniotic fluid; Endocrine disrupting chemicals; Fetal origin of disease; Preterm birth; Protein biomarker

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ANGIOGENIN; CELL ADHESION MOLECULE; ENDOCRINE DISRUPTOR; ENVIRONMENTAL CHEMICAL; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 6; PHYTOESTROGEN; POLYCHLORINATED BIPHENYL DERIVATIVE; PROSTAGLANDIN DERIVATIVE; TUMOR NECROSIS FACTOR; UROCORTIN I; BIOLOGICAL MARKER;

BIOMARKER; ENDOCRINE DISRUPTOR; ESTROGENIC COMPOUND; ETIOLOGY; HEALTH RISK; HERITABILITY; POLLUTION EXPOSURE; PREGNANCY; PUBLIC HEALTH; XENOBIOTICS;

AMNIOCENTESIS; AMNION FLUID; ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENVIRONMENTAL EXPOSURE; EXTRACELLULAR MATRIX; FETUS DEVELOPMENT; HEALTH CARE ACCESS; HOST RESISTANCE; HUMAN; HYGIENE; MONITORING; PREMATURE LABOR; PRENATAL DIAGNOSIS; PROTEIN EXPRESSION; PUBLIC HEALTH PROBLEM; PUBLIC HEALTH SERVICE; FEMALE; METABOLISM; PREGNANCY; RISK FACTOR;

UNITED STATES;

AMNIOTIC FLUID; BIOMARKERS; ENVIRONMENTAL EXPOSURE; FEMALE; FETAL DEVELOPMENT; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RISK FACTORS;

EID: 84911950240     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2014.09.031     Document Type: Review

References (122)

1. Adlercreutz H., et al. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J. Steroid Biochem. 1987, 27:1135-1144.
2. Adlercreutz H., et al. Dietary phytoestrogens and cancer: in vitro and in vivo studies. J. Steroid Biochem. Mol. Biol. 1992, 41:331-337.
3. Ames B.N., et al. The causes and prevention of cancer. Proc. Natl. Acad. Sci. USA 1995, 92:5258-5265.
4. Bamberg C., et al. Correlation of midtrimester amniotic fluid cytokine concentrations with adverse pregnancy outcome in terms of spontaneous abortion, preterm birth, and preeclampsia. J. Matern. Fetal Neonatal Med. 2012, 25:812-817.
5. Bamigboye A.A., et al. Diethylstilbestrol-haunting lessons. S. Afr. Med. J. 2003, 93:346-347.
6. Barker D.J., et al. Growth and chronic disease: findings in the Helsinki Birth Cohort. Ann. Hum. Biol. 2009, 36:445-458.
7. Barr D.B., et al. Concentrations of xenobiotic chemicals in the maternal-fetal unit. Reprod. Toxicol. 2007, 23:260-266.
8. Ben-Jonathan N., et al. Effects of bisphenol A on adipokine release from human adipose tissue: implications for the metabolic syndrome. Mol. Cell. Endocrinol. 2009, 304(1-2):49-54.
9. Blencowe H., et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012, 379:2162-2172.
10. Blount B.C., et al. Perinatal exposure to perchlorate. thiocyanate, and nitrate in New Jersey mothers and newborns. Environ Sci Technol. 2009, 43:7543-7549.
11. Boots A.B., et al. The short-term prediction of preterm birth: a systematic review and diagnostic metaanalysis. Am. J. Obstet. Gynecol. 2014, 210:54.e1-54.e10.
12. Bradman A., et al. Measurement of pesticides and other toxicants in amniotic fluid as a potential biomarker of prenatal exposure: a validation study. Environ. Health Perspect. 2003, 111:1779-1782.
13. Braniste V., et al. Impact of oral bisphenol A at reference doses on intestinal barrier function and sex differences after perinatal exposure in rats. Proc. Natl. Acad. Sci. USA 2010, 107:448-453.
14. Buhimschi C.S., et al. Fetal inflammatory response in women with proteomic biomarkers characteristic of intra-amniotic inflammation and preterm birth. Br. J. Obstet. Gynaecol. 2009, 116:257-267.
15. Buhimschi I.A., Buhimschi C.S. Proteomics of the amniotic fluid in assessment of the placenta.Relevance for preterm birth. Placenta 2008, 29:S95-S101.
16. Buhimschi I.A., Buhimschi C.S. Proteomics/diagnosis of chorioamnionitis and of relationships with the fetal exposome. Semin. Fetal Neonatal Med. 2012, 17:36-45.
17. Buhimschi I.A., et al. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. Br. J. Obstet. Gynaecol.-Int. J. Obstet. Gynaecol. 2005, 112:173-181.
18. Buhimschi I.A., et al. Advances in medical diagnosis of intra-amniotic infection. Expert Opin. Med. Diagn. 2013, 7:5-16.
19. Carlin D.J., et al. Unraveling the health effects of environmental mixtures: an NIEHS priority. Environ. Health Perspect. 2013, 121:A6-A8.
20. Casanova O.Q., et al. Detection of cocaine exposure in the neonate. Analyses of urine, meconium, and amniotic fluid from mothers and infants exposed to cocaine. Arch. Pathol. Lab. Med. 1994, 118:988-993.
21. Cassidy A., et al. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am. J. Clin. Nutr. 1994, 60:333-340.
22. Castorina R., et al. Comparison of current-use pesticide and other toxicant urinary metabolite levels among pregnant women in the CHAMACOS cohort and NHANES. Environ. Health Perspect. 2010, 118:856-863.
23. CDC, Preterm Birth, vol. 2013, 2013.
24. Chang H.H., et al. Time-to-event analysis of fine particle air pollution and preterm birth: results from North Carolina, 2001-2005. Am. J. Epidemiol. 2012, 175:91-98.
25. Chen M., et al. Determination of bisphenol-A levels in human amniotic fluid samples by liquid chromatography coupled with mass spectrometry. J. Sep. Sci. 2011, 34:1648-1655.
26. Cho C.K., et al. Proteomics analysis of human amniotic fluid. Mol. Cell. Proteomics 2007, 6:1406-1415.
27. Clayton E.M., et al. The impact of bisphenol A and triclosan on immune parameters in the U.S. population, NHANES 2003-2006. Environ. Health Perspect. 2011, 119(3):390-396. 10.1289/ehp.1002883.
28. Cobo T., et al. Predictive value of combined amniotic fluid proteomic biomarkers and interleukin-6 in preterm labor with intact membranes. Am. J. Obstet. Gynecol. 2009, 200.
29. Conde-Agudelo A., et al. Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysis. Br. J. Obstet. Gynaecol. 2011, 118:1042-1054.
30. DeFranco E.A., et al. Improving the screening accuracy for preterm labor: is the combination of fetal fibronectin and cervical length in symptomatic patients a useful predictor of preterm birth? A systematic review. Am. J. Obstet. Gynecol. 2013, 208:233.e1-233.e6.
31. Dekker G.A., et al. Risk factors for preterm birth in an international prospective cohort of nulliparous women. PLoS ONE 2012, 7:7.e39154.
32. Diamanti-Kandarakis E., et al. Endocrine-disrupting chemicals: an endocrine society scientific statement. Endocr. Rev. 2009, 30:293-342.
33. Dietert R.R., et al. Workshop to identify critical windows of exposure forchildren's health: immune and respiratory systems work group summar. Environ. Health Perspect. 2000, q108(Suppl. 3):483-490.
34. Eddleman K.A., et al. Pregnancy loss rates after midtrimester amniocentesis. Obstet. Gynecol. 2006, 108:1067-1072.
35. Edlow A.G., et al. Fetal bisphenol A exposure: concentration of conjugated and unconjugated bisphenol A in amniotic fluid in the second and third trimesters. Reprod. Toxicol. 2012, 34:1-7.
36. Edwards T.M., Myers J.P. Environmental exposures and gene regulation in disease etiology. Environ. Health Perspect. 2007, 115:1264-1270.
37. El-Bastawissi A.Y., et al. Amniotic fluid interleukin-6 and preterm delivery: a review. Obstet. Gynecol. 2000, 95:1056-1064.
38. Engel S.M., et al. Xenobiotic phenols in early pregnancy amniotic fluid. Reprod. Toxicol. 2006, 21:110-112.
39. Eyler F.D., et al. Relative ability of biologic specimens and interviews to detect prenatal cocaine use. Neurotoxicol .Teratol. 2005, 27:677-687.
40. Fennell T.R., et al. Pharmacokinetics of dibutylphthalate in pregnant rats. Toxicol. Sci. 2004, 82:407-418.
41. Figueroa R., et al. Evaluation of amniotic fluid cytokines in preterm labor and intact membranes. J. Matern. Fetal Neonatal Med. 2005, 18:241-247.
42. Foster W., et al. Detection of endocrine disrupting chemicals in samples of second trimester human amniotic fluid. J. Clin. Endocrinol. Metab. 2000, 85:2954-2957.
43. Foster W.G., et al. Detection of phytoestrogens in samples of second trimester human amniotic fluid. Toxicol. Lett. 2002, 129:199-205.
44. Gervasi M.T., et al. Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (<32 weeks) and late (>32 weeks) preterm delivery. J. Perinat. Med. 2012, 40:329-343.
45. Ghezzi F., et al. Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for preterm delivery. Am. J. Obstet. Gynecol. 2002, 186:268-273.
46. Gil M.M., et al. Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies. Ultrasound Obstet. Gynecol. 2013, 42:34-40.
47. Ginsberg G., Rice D.C. Does rapid metabolism ensure negligible risk from bisphenol A?. Environ. Health Perspect. 2009, 117:1639-1643.
48. Goldenberg R.L., et al. Maternal infection and adverse fetal and neonatal outcomes. Clin. Perinatol. 2005, 32:523-559.
49. Goldenberg R.L., et al. Intrauterine infection and preterm delivery. N. Engl. J. Med. 2000, 342:1500-1507.
50. Gotsch F., et al. The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation, and spontaneous parturition at term: a role for interleukin-10. J. Matern.-Fetal Neonatal Med. 2008, 21:529-547.
51. Graca G., et al. Metabolite profiling of human amniotic fluid by hyphenated nuclear magnetic resonance spectroscopy. Anal. Chem. 2008, 80:6085-6092.
52. Harirah H., et al. Amniotic fluid matrix metalloproteinase-9 and interleukin-6 in predicting intra-amniotic infection. Obstet. Gynecol. 2002, 99:80-84.
53. Herbstman J.B., et al. Determinants of prenatal exposure to polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs) in an urban population. Environ. Health Perspect. 2007, 115:1794-1800.
54. Holst R.M., et al. Prediction of microbial invasion of the amniotic cavity in women with preterm labour: analysis of multiple proteins in amniotic and cervical fluids. Br. J. Obstet. Gynaecol. 2011, 118:240-249.
55. Honest H., et al. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol. Assess. 2009, 13:1-627.
56. Huang P.C., et al. Association between prenatal exposure to phthalates and the health of newborns. Environ. Int. 2009, 35:14-20.
57. Inadera H. The immune system as a target for environmental chemicals: xenoestrogens and other compounds. Toxicol. Lett. 2006, 164:191-206.
58. Institute of Medicine Preterm Birth 2007, The National Academies Press, Washington, D.C.
59. Jacobson J.L., Jacobson S.W. Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N. Engl. J. Med. 1996, 335:783-789.
60. Jensen M.S. Phthalates and perfluorooctanesulfonic acid in human amniotic fluid: temporal trends and timing of amniocentesis in pregnancy. Environ. Health Perspect. 2012, 120:897-903.
61. Jusko T.A., et al. Pre- and postnatal polychlorinated biphenyl concentrations and longitudinal measures of thymus volume in infants. Environ. Health Perspect. 2012, 120:595-600.
62. Jusko T.A., et al. Reproducibility of urinary bisphenol A concentrations measured during pregnancy in the Generation R Study. J. Expo. Sci. Environ. Epidemiol. 2014, 24(5):532-536.
63. Han Y., et al. Acute cigarette smoke exposure modulates the inflammatory response in pdmH1N1 and H9N2 infection (P6190). J. Immunol. 2013, 190(189):10.
64. Karaer A.C., et al. Amniotic fluid urocortin-1 concentrations for the prediction of preterm delivery. J. Obstet. Gynaecol. Res. 2013, 39:1236-1241.
65. Kim A., et al. Identification of biomarkers for preterm delivery in mid-trimester amniotic fluid. Placenta 2013, 34:873-878.
66. Krupa F.G., et al. Predictors of preterm birth. Int. J. Gynaecol. Obstet. 2006, 94:5-11.
67. La Sala G.B., et al. Protein microarrays on midtrimester amniotic fluids: a novel approach for the diagnosis of early intrauterine inflammation related to preterm delivery. Int. J. Immunopathol. Pharmacol. 2012, 25:1029-1040.
68. Lee M.H., et al. Enhanced interleukin-4 production in CD4+ T cells and elevated immunoglobulin E levels in antigen-primed mice by bisphenol A and nonylphenol, endocrine disruptors: involvement of nuclear factor-AT and Ca2+. Immunology 2003, 109:76-86.
69. Lee S.Y., et al. IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes. J. Immunol. 2011, 186:3226-3236.
70. Lozano J., et al. Biological matrices for the evaluation of in utero exposure to drugs of abuse. Ther. Drug Monit. 2007, 29:711-734.
71. Liu J.Y., et al. Inhibition of soluble epoxide hydrolase contributes to the anti-inflammatory effect of antimicrobial triclocarban in a murine model. Toxicol. Appl. Pharmacol. 2011, 255:200-206.
72. Luzardo O.P., et al. Determinants of organochlorine levels detectable in the amniotic fluid of women from Tenerife Island (Canary Islands, Spain). Environ. Res. 2009, 109:607-613.
73. Madazli R., et al. Mid-trimester amniotic fluid angiogenin, lactate dehydrogenase and fibronectin in the prediction of preterm delivery. Eur. J. Obstet. Gynecol. Reprod. Biol. 2003, 106:160-164.
74. March of Dimes, Preterm Labor and Birth, vol. 2013, 2013.
75. Meeker J.D. Exposure to environmental endocrine disruptors and child development. Arch. Pediatr. Adolesc. Med. 2012, 166:952-958.
76. Menon R., et al. Racial disparity in pathophysiologic pathways of preterm birth based on genetic variants. Reprod. Biol. Endocrinol. 2009, 7:1-16. 10.1186/1477-7827-7-62.
77. Menon R., et al. Biomarkers of spontaneous preterm birth: an overview of the literature in the last four decades. Reprod. Sci. 2011, 18:1046-1070.
78. Menon R., Velez D.R. Genetic regulation of amniotic fluid TNF-alpha and soluble TNF receptor concentrations affected by race and preterm birth. Hum. Genet. 2008, 124:243-253.
79. Messina M., Messina V. Increasing use of soyfoods and their potential role in cancer prevention. J. Am. Diet Assoc. 1991, 91:836-840.
80. Miyabara Y., et al. Effects of diesel exhaust on allergic airway inflammation in mice. J. Allergy Clin. Immunol. 1998, 102:805-812.
81. Moore R.J., et al. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat. Med. 1999, 5:828-831.
82. Munoz-de-Toro M., et al. Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice. Endocrinology 2005, 146:4138-4147.
83. Mylchreest E., et al. Male reproductive tract malformations in rats following gestational and lactational exposure to Di(n-butyl) phthalate: an antiandrogenic mechanism?. Toxicol. Sci. 1998, 43:47-60.
84. Osmond C., Barker D.J. Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ. Health Perspect. 2000, 108(Suppl. 3):545-553.
85. Peretz J., et al. Bisphenol A and reproductive health: update of experimental and human evidence, 2007-2013. Environ. Health Perspect. 2014, 122(8):775-786.
86. Philippat C., et al. Prenatal exposure to environmental phenols: concentrations in amniotic fluid and variability in urinary concentrations during pregnancy. Environ. Health Perspect. 2013, 121(10):1225-1231. 10.1289/ehp.1206335.
87. Pietroiusti A., et al. Low doses of pristine and oxidized single-wall carbon nanotubes affect mammalian embryonic development. ACS Nano 2011, 5:4624-4633.
88. Pryor J.L., et al. Critical windows of exposure for children's health: the reproductive system in animals and humans. Environ. Health Perspect. 2000, 108(Suppl. 3):491-503.
89. Puchner K., et al. The implication of second-trimester amniotic fluid TNF-alpha, cytochrome C and cell death nucleosomes in the prediction of preterm labor and/or premature rupture of membranes. Arch. Gynecol. Obstet. 2012, 285:37-43.
90. Rakoff-Najoum S. Why cancer and inflammation. Yale J. Biol. Med. 2006, 79(3-4):123-130.
91. Reich E.S. Pre-term births on the rise. Nature 2012, 485:20.
92. Ripple M.G., et al. Detection of cocaine and its metabolites in human amniotic fluid. J. Anal. Toxicol. 1992, 16:328-331.
93. Ruiz R.J., et al. Second trimester maternal plasma levels of cytokines IL-1Ra, Il-6 and IL-10 and preterm birth. J. Perinatol. 2012, 32:483-490.
94. Rüetschi U., et al. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation. J. Proteome Res. 2005, 4:2236-2242.
95. Salafia C.M., et al. Circulating intercellular adhesion molecule-1 in amniotic fluid, maternal serum alpha-fetoprotein levels, and intrauterine growth retardation. Am. J. Obstet. Gynecol. 1993, 169:830-834.
96. Sapkota A., et al. Urinary biomarkers of 1,3-butadiene in environmental settings using liquid chromatography isotope dilution tandem mass spectrometry. Chem. Biol. Interact. 2006, 160:70-79.
97. Sharpe R.M., Skakkebaek N.E. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract?. Lancet 1993, 341:1392-1395.
98. Sherer D.M., Langer O. Oligohydramnios: use and misuse in clinical management. Ultrasound Obstet. Gynecol. 2001, 18:411-419.
99. Shimizu M., et al. Maternal exposure to nanoparticulate titanium dioxide during the prenatal period alters gene expression related to brain development in the mouse. Part Fibre Toxicol. 2009, 6:20.
100. Silva M.J., et al. Detection of phthalate metabolites in human amniotic fluid. Bull. Environ. Contam. Toxicol. 2004, 72:1226-1231.
101. Skakkebaek N.E., et al. Germ cell cancer and disorders of spermatogenesis: an environmental connection?. Acta Pathol. Microbiol. Immunol. Scand. 1998, 106:3-11. (discussion 12).
102. Spong C.Y., et al. Elevated maternal serum midtrimester alpha-fetoprotein levels are associated with fetoplacental ischemia. Am. J. Obstet. Gynecol. 1997, 177:1085-1087.
103. Steinmetz R., et al. The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. Endocrinology 1997, 138:1780-1786.
104. Takano H., et al. Diesel exhaust particles enhance antigen-induced airway inflammation and local cytokine expression in mice. Am. J. Respir. Crit. Care Med. 1997, 156:36-42.
105. Thomakos N., et al. Amniotic fluid interleukin-6 and tumor necrosis factor-alpha at mid-trimester genetic amniocentesis: relationship to intra-amniotic microbial invasion and preterm delivery. Eur. J. Obstet. Gynecol. Reprod. Biol. 2010, 148:147-151.
106. Vom Saal F.S., Hughes C. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ. Health Perspect. 2005, 113:926-933.
107. Vom Saal F.S., et al. The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol. Cell. Endocrinol. 2012, 354:74-84.
108. Vrachnis N., et al. Review: impact of mediators present in amniotic fluid on preterm labour. In Vivo 2012, 26:799-812.
109. Weissenbacher T., et al. Influence of maternal age, gestational age and fetal gender on expression of immune mediators in amniotic fluid. BMC Res. Notes 2012, 5:375.
110. Welshons W.V., et al. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ. Health Perspect. 2003, 111:994-1006.
111. Weiss A., et al. The matrix metalloproteinases (MMPS) in the decidua and fetal membranes. Front. Biosci. 2007, 12:649-659.
112. Wenstrom K.D., et al. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery. Am. J. Perinatol. 1997, 14:87-91.
113. Winecker R.E., et al. Detection of cocaine and its metabolites in amniotic fluid and umbilical cord tissue. J. Anal. Toxicol. 1997, 21:97-104.
114. Wira C.R., Sandoe C.P. Specific IgA and IgG antibodies in the secretions of the female reproductive tract: effects of immunization and estradiol on expression of this response in vivo. J. Immunol. 1987, 138:4159-4164.
115. Wittassek M., et al. Fetal exposure to phthalates--a pilot study. Int. J. Hyg. Environ. Health 2009, 212:492-498.
116. Wong D., et al. Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal testing. Clin. Biochem. 2013, 46:1099-1104.
117. World Health Organization State of the Science of Endocrine Disrupting Chemicals - 2012 2013, United Nations Environment Programme and the World Health Organization.
118. Yamada H., et al. Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester. Reprod. Toxicol. 2002, 16:735-739.
119. Yang H.M., et al. Effects of diesel exhaust particles (DEP), carbon black, and silica on macrophage responses to lipopolysaccharide: evidence of DEP suppression of macrophage activity. J. Toxicol. Environ. Health A 1999, 58:261-278.
120. Yang Y.J., et al. Bisphenol A exposure is associated with oxidative stress and inflammation in postmenopausal women. Environ. Res. 2009, 109(6):797-801. 10.1016/j.envres.2009.04.014.
121. Yin X.J., et al. Alteration of pulmonary immunity to Listeria monocytogenes by diesel exhaust particles (DEPs). I. Effects of DEPs on early pulmonary responses. Environ. Health Perspect. 2002, 110:1105-1111.
122. Yoon B.H., et al. An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am. J. Obstet. Gynecol. 2001, 185:1162-1167.